NFKB1 and nasopharyngeal carcinoma: Activation of NF-κB was seen in both NK and NPC cells when not treated with BMS-345541 after 24 h incubation with chemotherapeutic agents, as shown by immunoblot (Fig. 6a, c; Suppl.